Richard J. Hamill
- Infectious Diseases top 0.05%
- Epidemiology top 0.1%
- Surgery top 1%
- Public Health, Environmental and Occupational Health top 1%
- Molecular Biology top 10%
- Co-authors
- Daniel M. MusherPeter G. PappasWilliam G. PowderlyWilliam E. DismukesSamuel A. ShelburneRobert A. LarsenJohn R. GraybillJack D. Sobel
- Topics
- Fungal Infections and Studies (35 papers)Antifungal resistance and susceptibility (32 papers)Pneumocystis jirovecii pneumonia detection and treatment (13 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Richard J. Hamill
106 papers receiving 11.2k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Infectious Diseases 8.1k
- Epidemiology 7.9k
- Surgery 1.8k
- Public Health, Environmental and Occupational Health 1.2k
- Molecular Biology 781
Countries citing papers authored by Richard J. Hamill
This map shows the geographic impact of Richard J. Hamill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Hamill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Hamill more than expected).
Fields of papers citing papers by Richard J. Hamill
This network shows the impact of papers produced by Richard J. Hamill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Hamill. The network helps show where Richard J. Hamill may publish in the future.
Co-authorship network of co-authors of Richard J. Hamill
This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Hamill. A scholar is included among the top collaborators of Richard J. Hamill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Hamill. Richard J. Hamill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 8 | |
| 3 | Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicitybreakdown → | 546 |
| 4 | Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of Americabreakdown → | 1749 |
| 5 | 120 | |
| 6 | 17 | |
| 7 | 294 | |
| 8 | 57 | |
| 9 | 22 | |
| 10 | 144 | |
| 11 | A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patientsbreakdown → | 666 |
| 12 | 4 | |
| 13 | 204 | |
| 14 | Multi-drug-resistant cryptococcal meningitis in an AIDS patient | 1 |
| 15 | Concomitant crystal and septic arthritis. | 19 |
| 16 | 20 | |
| 17 | 32 | |
| 18 | 3 | |
| 19 | 18 | |
| 20 | 12 |
About Richard J. Hamill
Richard J. Hamill is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine, having authored 109 papers that have together received 11.6k indexed citations. Recurring topics across this work include Fungal Infections and Studies (35 papers), Antifungal resistance and susceptibility (32 papers) and Pneumocystis jirovecii pneumonia detection and treatment (13 papers). The work is most often cited by research in Infectious Diseases (8.1k citations), Epidemiology (7.9k citations) and Applied Microbiology and Biotechnology (151 citations). Richard J. Hamill has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Daniel M. Musher, Peter G. Pappas, William G. Powderly, William E. Dismukes, Samuel A. Shelburne, Robert A. Larsen, John R. Graybill, Jack D. Sobel, Stephen B. Greenberg and Rabih O. Darouiche. Their work appears in journals such as New England Journal of Medicine, Annals of Internal Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.